Danny Ben-Avraham received his Ph.D. from the Hebrew University. After completion of his degree, he spent three years as a research fellow in the institute for Aging Research at the Albert Einstein College of Medicine (NY) where his research focus was the human genome and epigenome and its impact on aging and longevity. Prior to joining the Center, Danny worked at Proteologics Ltd., a biopharmaceutical company that specializes in the ubiquitin system, as the Head of Bio & Cheminformatics group. In this role, he built expert systems, used statistical methods and advanced techniques in computer-aided drug design such as QSAR, Pharmachophores, Docking and homology modeling. Previously, he worked at Quark Biotech Inc., as an Advanced Annotation team leader in the Bioinformatics group, and at Comverse Technology, Inc. as a programmer and activity leader.
Shlomit earned her Ph.D. in human genetics from Tel-Aviv University. Prior to joining the Center, Shlomit worked for 15 years at the Israeli companies QBI and Rosetta Genomics. During this period Shlomit co-developed diagnostic assays from the initial idea to market. She has many years of experience in developing novel molecular biology protocols and managing R&D teams. Shlomit is an expert in many molecular biology techniques and has seven US patents for novel methods and compositions and 34 peer reviewed publications. Shlomit Joined the Center in September, 2012, as Head of R&D and was recently promoted to Platform Head.